Pharma/Biotech Update: Baxter Reveals Trial Results for vWD Drug
For those suffering from von Willebrand Disease (vWD) a new pharmaceutical option may be available to you at the beginning…
Posts by Category: News
Pharma/BioTech Update: Biogen Idec’s Hemophilia Drug Price to Remain on Par
An article released today by FiercePharma stated that Biogen Idec’s new hemophilia B drug, Alprolix, will be priced similarly to older and…
British Mother Finds Hope in Non-Conventional Medicine
A good deal of people out there are forced to cope with a life altering and possibly ending disease, however,…
Pharma/Biotech Update: Eloctate Meets Objectives in Hemophilia A Study
A recent article written by Michael Calia at NASDAQ shows promise for Biogen Idec’s up and coming hemophilia A (factor VIII deficiency)…
Pharma/Biotech Update: Boehringer Ingelheim Receives FDA Approval for Blood Clots
In an article from earlier today via FiercePharma, pharmaceutical giant Boehringer Ingelheim’s (BI) drug Pradaxa has recently been given the…
Hepatitis C Drug Receives Priority Review
According to an article released by NASDAQ today, the United States Food and Drug Administration (FDA) has taken their “breakthrough…
DVT: Lawsuit Filed as Critical Care Nurse Examines Practice Habits
A Huntsville, Alabama skilled nursing facility has been named in a lawsuit according to AL.com, claiming that facility failed to…
Chances of Blood Clots Elevated in Those With Lung Cancer
According to a recent study summarized in an About.Com article, the risk of blood clots in cancer patients is elevated for many reasons….
Pharma/Biotech Update: Biogen Idec’s Long Acting Drug Receives FDA Approval
The wait is over. Biogen Idec has officially received word from the U.S. Food and Drug Administration about the approval of…
Pharma/Biotech Update: Baxter To Add Public Company in 2015
Baxter International Inc. has announced plans to spin-off it’s biotech division and make that area of business its own company….